Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Cell. Infect. Microbiol.

Sec. Virus and Host

Volume 15 - 2025 | doi: 10.3389/fcimb.2025.1671738

Vitamin D-inducible Antimicrobial Peptide LL-37 binds SARS-CoV-2 Spike and Open Reading Frame Proteins 7a and 8

Provisionally accepted
Annika  RothAnnika Roth1Steffen  LütkeSteffen Lütke1Matthias  MörgelinMatthias Mörgelin2Denise  MeinbergerDenise Meinberger1Gabriele  HermesGabriele Hermes1Manuel  KochManuel Koch1,3Gerhard  SengleGerhard Sengle1,3,4Marco  DrexeliusMarco Drexelius5Ines  NeundorfInes Neundorf5Jan  GebauerJan Gebauer5Dzemal  ElezagicDzemal Elezagic1*Mats  PaulssonMats Paulsson1,3Thomas  StreichertThomas Streichert1Andreas  R. KlattAndreas R. Klatt1
  • 1Universitatsklinikum Koln, Cologne, Germany
  • 2Lunds Universitet, Lund, Sweden
  • 3University of Cologne Center for Molecular Medicine Cologne, Cologne, Germany
  • 4Universitat zu Koln Institut fur Biochemie, Cologne, Germany
  • 5Universitat zu Koln Zentrum Biochemie, Cologne, Germany

The final, formatted version of the article will be published soon.

Background: The role of vitamin D in Coronavirus Disease 2019 (COVID-19) outcomes remains debated, but emerging evidence suggests it may enhance recovery by strengthening immune responses. Vitamin D upregulates LL-37, an antimicrobial peptide with broad antiviral activity, including potential benefits against SARS-CoV-2. LL-37's interactions with viral proteins, however, remain incompletely understood. Methods: We investigated LL-37's interactions with the SARS-CoV-2 Spike glycoprotein and the accessory proteins ORF7a and ORF8 using surface plasmon resonance and negative-stain electron microscopy. These approaches were employed to assess LL-37's binding capabilities and potential impact on viral infectivity. Results: LL-37 bound multiple domains of the Spike protein and inhibited its interaction with the human angiotensin-converting enzyme 2 (hACE2) receptor in vitro. Up to seven LL-37 molecules were observed surrounding Spike, forming a halo-like structure that may block receptor engagement. LL-37 also bound to ORF7a and ORF8, potentially impairing their ability to disrupt host cell processes. Notably, LL-37's interaction with ORF7a may prevent degradation of SNAP29, restoring autophagy and promoting viral clearance. Conclusions: LL-37 disrupts key viral-host interactions by binding to Spike, ORF7a, and ORF8, thereby reducing SARS-CoV-2 infectivity. These findings highlight LL-37's potential as a therapeutic agent in COVID-19 and provide mechanistic insight into its antiviral actions.

Keywords: SARS-CoV-2, COVID-19, Spike, ORF7a, orf8, LL-37, Surface Plasmon Resonance, Vitamin D

Received: 23 Jul 2025; Accepted: 01 Sep 2025.

Copyright: © 2025 Roth, Lütke, Mörgelin, Meinberger, Hermes, Koch, Sengle, Drexelius, Neundorf, Gebauer, Elezagic, Paulsson, Streichert and Klatt. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Dzemal Elezagic, Universitatsklinikum Koln, Cologne, Germany

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.